BridgeBio (BBIO) reports Q2 loss of $152.2 million, $0.78 per share

BBIO BridgeBio Pharma Inc

$68.12 +0.56%

View chart & analysis →

1. 1BridgeBio Pharma (BBIO) reported a Q2 net loss of $152.2 million, or $0.78 per share.
2. 2The loss per share exceeded the Wall Street estimate of $0.64, while revenue of $243.7 million came in above the expected $222.6 million.
3. 3Shares are up 11% year-to-date and rose 82% over the past year, closing Monday at $85.

Source Associated Press +1 · View original ↗

Today's 5 AI picks, all free

Nothing hidden: past picks and how they did against the S&P 500.

See today's picks →